Search results
CPET and Exercise Prescription for Cardiac Rehabilitation
Author(s):
Kaoutar Kabbadj
,
Nora Taiek
,
Wiame El Hjouji
,
et al
Added:
1 year ago
Review Article
Exploring Exercise-induced Long QT
Author(s):
William Wiradinata
,
Anita Dominique Subali
,
Muhammad Reva Aditya
Added:
6 months ago
Review Article
Author(s):
Mikhail Kosiborod
Added:
1 year ago
HFSA 24 - We are joined virtually by Dr Mikhail Kosiborod (Saint Luke’s Mid America Heart Institute, US) to discuss findings from the STEP-HFpEF trial programme in regard to the efficacy of semaglutide according to frailty status, and exercise function at baseline.Interview Questions:1. Could you remind us of the importance of STEP-HFpEF2. What was the study design and patient population?3. What…
View more
Author(s):
Oliver Mithoefer
,
Jacob Read
,
Carson Keck
,
et al
Added:
2 years ago
Author(s):
Gregory Lewis
Added:
4 months ago
HFSA 25 - Aficamten improves excercise capacity compared to metoprolol in patients with obstructive hypertrophic cardiomyopathy in a prespecified analysis of the MAPLE-HCM study.Dr Gregory Lewis joins us to discuss findings from a prespecified cardiopulmonary exercise testing analysis of the MAPLE-HCM trial, which reveals divergent effects between aficamten and metoprolol on exercise performance…
View more
Peter H Brubaker
Research Area(s) / Expertise:
Job title: Professor in the Department of Health and Exercise Science and Executive Director of Healthy Exercise and Lifestyle ProgramS (HELPS)
Author
Jamie M O’Driscoll
Job title: Reader in Cardiovascular Physiology
Author
Author(s):
Marat Fudim
Added:
1 year ago
THT Conference 2025 - Findings show catheter ablation of the right greater splanchnic nerve (GSN) in patients with heart failure with preserved ejection fraction (HFpEF) reduced estimated stressed blood volume in patients whether the ablation caused clinical benefits or not. This outcome indicates a confirmation of technical success that correlates with prior single-arm study findings.Dr Marat…
View more
Author(s):
Harriette Van Spall
,
James L Januzzi
Added:
1 year ago
ACC 2024 — Late-breaker host Dr Harriette Van Spall (McMaster University, CA) sits down with Dr James L. Januzzi (Massachusetts General Hospital & Harvard Medical School, US) to discuss the latest findings from the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure trial (ARISE-HF, Applied Therapeutics, Inc) (NCT04083339).This phase 3 multicenter, randomized,…
View more
Bernard R Chaitman
Research Area(s) / Expertise:
Job title: Professor of Medicine and Director of Cardiovascular Research
Author